35.97 M EUR
224.92 M EUR
1.39 M
About CLINICA BAVIERA S.A.
Sector
Industry
CEO
Eduardo Baviera Sabater
Website
Headquarters
Madrid
Founded
1992
ISIN
ES0119037010
FIGI
BBG000R3L5M4
Clínica Baviera SA is engaged in the provision of diagnosis and treatment for eye disorders. It specializes in the treatment of glaucoma, cataract, vitreous and retinal detachment, and strabismus or squinting. The company was founded by Eduardo Baviera Sabater, Julio Baviera Sabater, Luis Miguel Raga, and Fernando Llovet Osuna on February 5, 1992 and is headquartered in Madrid, Spain.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of D9Z is 31.70 EUR — it has increased by 1.28% in the past 24 hours. Watch CLINICA BAVIERA SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange CLINICA BAVIERA SA stocks are traded under the ticker D9Z.
D9Z stock has risen by 3.59% compared to the previous week, the month change is a −3.65% fall, over the last year CLINICA BAVIERA SA has showed a 37.23% increase.
We've gathered analysts' opinions on CLINICA BAVIERA SA future price: according to them, D9Z price has a max estimate of 26.30 EUR and a min estimate of 26.30 EUR. Watch D9Z chart and read a more detailed CLINICA BAVIERA SA stock forecast: see what analysts think of CLINICA BAVIERA SA and suggest that you do with its stocks.
D9Z stock is 2.59% volatile and has beta coefficient of 0.38. Track CLINICA BAVIERA SA stock price on the chart and check out the list of the most volatile stocks — is CLINICA BAVIERA SA there?
Today CLINICA BAVIERA SA has the market capitalization of 508.63 M, it has decreased by −2.52% over the last week.
Yes, you can track CLINICA BAVIERA SA financials in yearly and quarterly reports right on TradingView.
D9Z net income for the last quarter is 4.05 M EUR, while the quarter before that showed 12.41 M EUR of net income which accounts for −67.34% change. Track more CLINICA BAVIERA SA financial stats to get the full picture.
CLINICA BAVIERA SA dividend yield was 5.53% in 2023, and payout ratio reached 57.64%. The year before the numbers were 6.03% and 58.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jan 1, 2025, the company has 1.47 K employees. See our rating of the largest employees — is CLINICA BAVIERA SA on this list?
Like other stocks, D9Z shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CLINICA BAVIERA SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CLINICA BAVIERA SA technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CLINICA BAVIERA SA stock shows the neutral signal. See more of CLINICA BAVIERA SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.